Arkema finalized the divestment of Febex, a company specialized in phosphorus-based chemistry, to Belgian group Prayon on January 3, 2023. Febex produces phosphorus derivatives (high-purity phosphoric acid, sodium hypophosphite, and derivatives), used primarily in electronics and in the pharmaceuticals industry.
The company was a part of Arkema’s performance additives business line, and existed with little integration within the group’s other activities. Febex reported sales of around €30 million in 2021, employs 59 people, and operates one site in Switzerland.
For more information, visit: https://www.arkema.com/.